TY  - JOUR
AU  - Rodríguez Carreiro, Santiago
AU  - Gómez Cañas, María
AU  - Lubrini, Francesca
AU  - Gonzalo Consuegra, Claudia
AU  - Winkler, Matthias
AU  - Caprioglio, Diego
AU  - Appendino, Giovanni
AU  - García García, María De La Concepción
AU  - Morales, Paula
AU  - Jagerovic, Nadine
AU  - Fischer, Joerg T.
AU  - Fiebich, Bernd L.
AU  - Goetz, Marcus R.
AU  - Muñoz, Eduardo
AU  - Fernández Ruiz, José Javier
PY  - 2025
DO  - 10.1016/j.ejmcr.2025.100262
SN  - 2772-4174
UR  - https://hdl.handle.net/20.500.14352/133378
T2  - European Journal of Medicinal Chemistry Reports
AB  - Cannabidiol (CBD) and cannabidivarin (CBDV) have shown promising clinical efficacy for the management of epilepsy, and beneficial effects have been demonstrated for CBD in a diversity of other pathologies (pain, schizophrenia, Tourette syndrome,...
LA  - eng
M2  - 100262
PB  - Elsevier
KW  - CBD
KW  - CBDV
KW  - CBDA-Derivatives
KW  - (−)- and (+)-enantiomers
KW  - CB1 receptor
KW  - CB2 receptor
KW  - Binding
KW  - Agonist
KW  - Inverse agonist
KW  - Antagonist
KW  - Anti-inflammatory
KW  - neuroprotective effects
TI  - Investigation in the CB1 and CB2 receptor binding profile and intrinsic activity of (−) and (+)-enantiomers of some naturally occurring phytocannabinoids or synthetic derivatives
TY  - journal article
VL  - 14
ER  -